Abstract
Enzymes fuel the biochemical activities of all cells. Their substrates and products thus represent a potential window into the physiologic state of a cell. Metabolomics focuses on the global, or systems-level, study of small molecules in a given biological system and has thus provided an experimental tool with which to study cellular physiology, including the biochemistry within pathogenic microorganisms. While metabolomic studies of Mycobacterium tuberculosis are still in their infancy, recent studies have begun to deliver unique insights into the composition, organization, activity, and regulation of the bacterium’s physiologic network not accessible by other approaches. Here, we outline practical methods for the culture, collection, and analysis of metabolomic samples from M. tuberculosis that emphasize minimally perturbing sample handling, broad and native metabolite recovery, and sensitive, biologically agnostic metabolite detection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Patti GJ, Yanes O, Siuzdak G (2012) Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 13(4):263–269
Reaves ML, Rabinowitz JD (2011) Metabolomics in systems microbiology. Curr Opin Biotechnol 22(1):17–25
Rhee KY, Carvalho LP, Bryk R, Ehrt S, Marrero J, Park SW, Schnappinger D, Venugopal A, Nathan C (2011) Central carbon metabolism in mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol 7:307–314
Saghatelian A, Cravatt BF (2005) Global strategies to integrate the proteome and metabolome. Curr Opin Chem Biol 9(1):62–68
de Carvalho LP, Zhao H, Dickinson CE, Arango NM, Lima CD, Fischer SM, Ouerfelli O, Nathan C, Rhee KY (2010) Activity-based metabolomic profiling of enzymatic function: identification of rv1248c as a mycobacterial 2-hydroxy-3-oxoadipate synthase. Chem Biol 17(4):323–332
Larrouy-Maumus G, Biswas T, Hunt DM, Kelly G, Tsodikov OV, de Carvalho LP (2013) Discovery of a glycerol 3-phosphate phosphatase reveals glycerophospholipid polar head recycling in mycobacterium tuberculosis. Proc Natl Acad Sci U S A 110(28):11320–11325
de Carvalho LP, Fischer SM, Marrero J, Nathan C, Ehrt S, Rhee KY (2010) Metabolomics of mycobacterium tuberculosis reveals compartmentalized co-catabolism of carbon substrates. Chem Biol 17(10):1122–1131
Eoh H, Rhee KY (2013) Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in mycobacterium tuberculosis. Proc Natl Acad Sci U S A 110(16):6554–6559
Marrero J, Rhee KY, Schnappinger D, Pethe K, Ehrt S (2010) Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for mycobacterium tuberculosis to establish and maintain infection. Proc Natl Acad Sci U S A 107(21):9819–9824
Marrero J, Trujillo C, Rhee KY, Ehrt S (2013) Glucose phosphorylation is required for mycobacterium tuberculosis persistence in mice. PLoS Pathog 9(1):e1003116
Eoh H, Rhee KY (2014) Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of mycobacterium tuberculosis on fatty acids. Proc Natl Acad Sci U S A 111(13):4976–4981
Ganapathy U, Marrero J, Calhoun S, Eoh H, de Carvalho LP, Rhee K, Ehrt S (2015) Two enzymes with redundant fructose bisphosphatase activity sustain gluconeogenesis and virulence in Mycobacterium tuberculosis. Nat Commun 6(1):1–12
Maksymiuk C, Balakrishnan A, Bryk R, Rhee KY, Nathan CF (2015) E1 of alpha-ketoglutarate dehydrogenase defends Mycobacterium tuberculosis against glutamate anaplerosis and nitroxidative stress. Proc Natl Acad Sci U S A 112(43):E5834–E5843
Noy T, Vergnolle O, Hartman TE, Rhee KY, Jacobs WR, Berney M, Blanchard JS (2016) Central role of pyruvate kinase in carbon co-catabolism of Mycobacterium tuberculosis. J Biol Chem 291(13):7060–7069
Warrier T, Kapilashrami K, Argyrou A, Ioerger TR, Little D, Murphy KC, Nandakumar M, Park S, Gold B, Mi J, Zhang T, Meiler E, Rees M, Somersan-Karakaya S, Porras-De Francisco E, Martinez-Hoyos M, Burns-Huang K, Roberts J, Ling Y, Rhee KY, Mendoza-Losana A, Luo M, Nathan CF (2016) N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 113(31):E4523–E4530
Eoh H, Wang Z, Layre E, Rath P, Morris R, Moody DB, Rhee KY (2017) Metabolic anticipation in Mycobacterium tuberculosis. Nat Microbiol 2(8):17084
Puckett S, Trujillo C, Wang Z, Eoh H, Ioerger TR, Krieger I, Sacchettini J, Schnappinger D, Rhee KY, Ehrt S (2017) Glyoxylate detoxification is an essential function of malate synthase required for carbon assimilation in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 114(11):E2225–E2232
Ruecker N, Jansen R, Trujillo C, Puckett S, Jayachandran P, Piroli GG, Frizzell N, Molina H, Rhee KY, Ehrt S (2017) Fumarase deficiency causes protein and metabolite succination and intoxicates Mycobacterium tuberculosis. Cell Chem Biol 24(3):306–315
Chakraborty S, Gruber T, Barry CE 3rd, Boshoff HI, Rhee KY (2013) Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in mycobacterium tuberculosis. Science 339(6115):88–91
Kwon YK, Higgins MB, Rabinowitz JD (2010) Antifolate-induced depletion of intracellular glycine and purines inhibits thymineless death in E. coli. ACS Chem Biol 5(8):787–795
Kwon YK, Lu W, Melamud E, Khanam N, Bognar A, Rabinowitz JD (2008) A domino effect in antifolate drug action in Escherichia coli. Nat Chem Biol 4(10):602–608
Bockman MR, Kalinda AS, Petrelli R, De la Mora-Rey T, Tiwari D, Liu F, Dawadi S, Nandakumar M, Rhee KY, Schnappinger D, Finzel BC, Aldrich CC (2015) Targeting Mycobacterium tuberculosis biotin protein ligase (MtBPL) with nucleoside-based bisubstrate adenylation inhibitors. J Med Chem 58(18):7349–7369
Park Y, Pacitto A, Bayliss T, Cleghorn LAT, Wang Z, Hartman T, Arora K, Ioerger TR, Sacchettini J, Rizzi M, Donini S, Blundell TL, Ascher DB, Rhee K, Breda A, Zhou N, Dartois V, Jonnala SR, Via LE, Mizrahi V, Epemolu O, Stojanovski L, Simeons F, Osuna-Cabello M, Ellis L, MacKenzie CJ, Smith ARC, Davis SH, Murugesan D, Buchanan KI, Turner PA, Huggett M, Zuccotto F, Rebollo-Lopez MJ, Lafuente-Monasterio MJ, Sanz O, Santos Diaz G, Lelievre J, Ballell J, Selenski C, Axtman M, Ghidelli-Disse S, Pflaumer H, Bosche M, Drewes G, Freiberg GM, Kurnick MD, Srikumaran M, Kempf DJ, Green SR, Ray PC, Read K, Wyatt P, Barry CE, Boshoff HI (2016) Essential but not vulnerable: indazole sulfonamides targeting inosine monophosphate dehydrogenase as potential leads against Mycobacterium tuberculosis. ACS Infect Dis 3(1):18–33
Chen C, Gardete S, Jansen RS, Shetty A, Dick T, Rhee KY, Dartois V (2018) Verapamil targets membrane energetics in Mycobacterium tuberculosis. Antimicrob Agents Chemother 62(5):e02107–e02117
Ballinger E, Mosior J, Hartman T, Burns-Huang K, Gold B, Morris R, Goullieux L, Blanc I, Vaubourgeix J, Lagrange S, Fraisse L, Sans S, Couturier C, Bacque E, Rhee K, Scarry SM, Aube J, Yang G, Ouerfelli O, Schnappinger D, Ioerger TR, Engelhart CA, McConnell JA, McAulay K, Fay A, Roubert C, Sacchettini J, Nathan C (2019) Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition. Science 363(6426):eaau8959
Wang Z, Soni V, Marriner G, Kaneko T, Boshoff HIM, Barry CE, Rhee KY (2019) Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline. Proc Natl Acad Sci U S A 116(39):19646–19651
Villas-Boas SG, Mas S, Akesson M, Smedsgaard J, Nielsen J (2005) Mass spectrometry in metabolome analysis. Mass Spectrom Rev 24(5):613–646
Acknowledgment
Authors M. Nandakumar and LPS de Carvalho contributed to the previous version of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Planck, K.A., Rhee, K. (2021). Metabolomics of Mycobacterium tuberculosis . In: Parish, T., Kumar, A. (eds) Mycobacteria Protocols. Methods in Molecular Biology, vol 2314. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1460-0_25
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1460-0_25
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1459-4
Online ISBN: 978-1-0716-1460-0
eBook Packages: Springer Protocols